dr. gitlitz discusses the genomics of young lung cancer study
Published 8 years ago • 371 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
1:44
dr. lopategui on the implications of genomic sequencing in lung cancer
-
1:32
dr. gettinger on the evolution of immunotherapies in lung cancer
-
2:26
dr. pennell on the underutilization of genetic testing in lung cancer
-
58:51
disrupting the lung cancer care continuum with novel genomic tests
-
1:02:53
what's happening with cancer genomics?
-
48:22
lung cancer evolution and immune escape
-
5:09
immunotherapy for lung cancer: general concepts
-
18:32
genomic diagnosis and the revolution in medicine - prof leslie burnett
-
2:04
genomic testing personalizes lung cancer treatments
-
1:00:12
genomics lite: cancer research the big questions with dr alastair droop
-
2:09
dr. jänne on biomarker results from a study of azd9291
-
1:25:38
2021 liquid biopsy eqa for lung cancer (egfr) webinar - 21st april 2022
-
22:56
egfr and the inherit study
-
58:52
takeda & gryt health presents: improving health equity in lung cancer
-
8:39
discussing maintenance therapy with patients
-
1:25
dr. jacques galipeau: immunotherapy and cancer-immune cell hormones (cytokines)
-
1:17
dr. kelly on the javelin solid tumor trial
-
1:09:02
redefining cancer with integrative tumor immunology: novel cutting edge immunotherapies for patients